Abstract
Introduction
Following the declaration of the COVID-19 pandemic, the Democratic Republic of Congo (DRC), under the coordination of the Presidency of the Republic through the Multisectoral Response Committee against COVID-19, implemented measures recommended by the World Health Organization, including screening, adherence to barrier measures, and vaccination.
Purpose
This study aimed to explore healthcare workers’ perceptions of and attitudes towards COVID-19 vaccination at Kintambo General Referral Hospital in Kinshasa, and to identify factors influencing vaccine acceptability, hesitancy, and refusal.
Methods
An exploratory qualitative study was conducted among healthcare workers at Kintambo General Referral Hospital. Data were collected using surveys and semi-structured interviews and analysed through thematic and categorical analysis.
Results
Initial perceptions of the COVID-19 vaccine were largely negative, with the vaccine perceived as a poison, a tool for population control, a masquerade, or a population sterilisation strategy. Over time, these perceptions became more positive, with vaccination increasingly viewed as a protective measure with moderately accepted effectiveness. Vaccine acceptability depended on production by a reputable laboratory, absence of significant side effects, and voluntary administration. Motivations for vaccination included perceived occupational exposure to COVID-19 and professional responsibility. Reasons for refusal included misinformation disseminated on social media, controversies surrounding early vaccines, limited knowledge about COVID-19, doubts about vaccine safety and effectiveness, fear of side effects, and the politicisation of vaccination.
Conclusion
The findings indicate that concerns about COVID-19 vaccination persist among healthcare workers. Strengthening targeted awareness and communication strategies that clearly explain scientific evidence and clinical trial results is essential to improve confidence in vaccines. Addressing misinformation and promoting evidence-based decision-making are critical to enhancing vaccine acceptance among healthcare workers and the general population.
References
Baribeau, C. (2019). Recherches qualitatives : Apport de la revue au développement de la recherche qualitative. Recherches qualitatives, 38(1), 141 161. https://doi.org/10.7202/1059652ar
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021). COVID-19 vaccines : The status and perspectives in delivery points of view. Advanced Drug Delivery Reviews, 170, 1 25. https://doi.org/10.1016/j.addr.2020.12.011
Demoncy, A. (2016). La recherche qualitative : Introduction à la méthodologie de l’entretien. Kinésithérapie, la Revue, 16(180), 32 37. https://doi.org/10.1016/j.kine.2016.07.004
Desclaux, A., Bila, B., Sow, K., Varloteaux, M., & Houngnihin, R. A. (2020). Les populations d’Afrique sont-elles prêtes à accepter le vaccin anti-Covid-19 ? The Conversation. http://theconversation.com/les-populations-dafrique-sont-elles-pretes-a-accepter-le-vaccin-anti-covid-19-149104
Fortin, M.-F., & Gagnon, J. (2010). Fondements et étapes du processus de recherche : Méthodes quantitatives et qualitatives. Chenelière Education.
Fourboul, C. V. (2020). Analyser les données qualitatives en gestion. BoD - Books on Demand.
Gao, T., Xu, Y., He, X., Xu, X., Wang, L., Jiang, Y., Wu, C., & Zhang, W. (2021). Epidemiological and clinical characteristics of 40 cases of COVID-19 outside Hubei Province, China. Food Science and Technology. https://doi.org/10.1590/fst.17321
Ge, H., Wang, X., Yuan, X., Xiao, G., Wang, C., Deng, T., Yuan, Q., & Xiao, X. (2020). The epidemiology and clinical information about COVID-19. European Journal of Clinical Microbiology & Infectious Diseases, 1 9. https://doi.org/10.1007/s10096-020-03874-z
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion Jr, T. R., Nahid, M., & Ringel, J. B. (2020). Clinical characteristics of Covid-19 in New York city. New England Journal of Medicine.
Group, R. C. (2020). Dexamethasone in hospitalized patients with Covid-19—Preliminary report. New England Journal of Medicine.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395. https://doi.org/10.1016/S0140-6736(20)30183-5
Jaffré, Y. (1999). Les services de santé « pour de vrai ». Politiques sanitaires et interactions quotidiennes dans quelques centres de santé (Bamako, Dakar, Niamey). Bulletin de l’APAD, 17, Article 17. http://journals.openedition.org/apad/475
Jia, Z., & Gong, W. (2021). Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines? Journal of Korean Medical Science, 36(18), e124. https://doi.org/10.3346/jkms.2021.36.e124
Lévy-Bruhl, D., Cook, J., Legonou, B., Jaffré, Y., Amévigbe, P. D., Sanou, G., & Guérin, N. (1993). Approches méthodologiques dans l’étude de l’acceptabilité de la vaccination : Exemple de trois enquêtes menées en Afrique de l’Ouest. Sciences Sociales et Santé, 11(2), 9 25. https://doi.org/10.3406/sosan.1993.1262
Mabakutuvangilanga Ntela SD et Rothan-Tondeur Monique. (2021). Covid-19 dans la ville de Kinshasa : Représentations sociales chez les fugitifs du confinement. InterdisciplinaryResearchJournal and archive. https://doi.org/10.36966/irjar2021.1
Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., Xiong, Y., Cheng, Z., Gao, S., & Liang, K. (2020). Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical Infectious Diseases.
WHO. (2020a). Coronavirus disease 2019 (COVID-19) : Situation report, 72.
WHO. (2020b). Coronavirus disease 2019 (COVID-19) : Situation report, 82.
Restivo, L., Julian-Reynier, C., & Apostolidis, T. (2018). Pratiquer l’analyse interprétative phénoménologique : Intérêts et illustration dans le cadre de l’enquête psychosociale par entretiens de recherche. Pratiques Psychologiques, 24(4), 427 449. https://doi.org/10.1016/j.prps.2017.12.001
WHO. (2019). Introduction du vaccin contre la COVID-19 : Orientations pour l’identification des groupes prioritaires et la micro-planification. Version 1, 18 janvier 2021. Pan American health organization. https://iris.paho.org/handle/10665.2/53319
Zellweger, J.-P. (2021). Information sur le vaccin contre le COVID-19. Bulletin des médecins suisses, 102(07), 242 243. https://doi.org/10.4414/bms.2021.19624
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., & Zhang, H. (2020). Coagulopathy and antiphospholipid antibodies in patients with Covid-19. New England Journal of Medicine, 382(17), e38.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
